List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #18,581 to #18,630.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. EMG → Electromyography
  2. EMG syndrome → Beckwith-Wiedemann syndrome
  3. EMIAT → European Myocardial Infarction Amiodarone Trial
  4. EMIP → Prehospital Thrombolytic Therapy In Patients With Suspected Acute Myocardial Infarction
  5. EMIP-FR → European Myocardial Infarction Project—Free Radicals
  6. EMIT → European Mivazerol Trial
  7. EMPD → Extramammary Paget's disease
  8. EMPIRIC → Comparison Of Empiric To Physician-Tailored Programming Of Implantable Cardioverter Defibrillators Trial
  9. EMT-Intermediate → Emergency medical technician-intermediate
  10. EMTALA → Emergency Medical Treatment and Active Labor Act
  11. EMTs → Emergency medical technician
  12. ENA-78 → CXCL5
  13. ENABLE → Effects Of The Endothelin Receptor Antagonist Bosentan On The Morbidity And Mortality In Patients With Chronic Heart Failure
  14. ENA 713 → Rivastigmine (patient information)
  15. ENCOR → Enrasentan Cooperative Randomized Evaluation
  16. ENCORE I → Evaluation Of Nifedipine And Cerivastatin On Recovery Of Coronary Endothelial Function
  17. ENCORE II → Long-Term Effect Of Nifedipine On Vasomotion And Vessel Morphology In Patients With Coronary Artery Disease: An Intravascular Ultrasound-Assisted Evaluation
  18. ENDEAVOR-1 → Multicenter Evaluation Of Abt-578 Elution From A Phosphorylcholine-Coated Stent
  19. ENDEAVOR II → Randomized Comparison Of The Endeavor Abt-578 Drug Eluting Stent With A Bare Metal Stent For Coronary Revascularization
  20. ENDEAVOR III → Randomized Comparison Of Zotarolimus-Eluting And Sirolimus-Eluting Stents In Patients With Coronary Artery Disease-3
  21. ENDEAVOR IV → Randomized Comparison Of Zotarolimus-Eluting And Paclitaxel-Eluting Stents In Patients With Coronary Artery Disease-4
  22. ENHANCE → Simvastatin With Or Without Ezetimibe In Familial Hypercholesterolemia
  23. ENO2 → Enolase 2
  24. ENRICHD → Enhancing Recovery In Coronary Heart Disease
  25. ENTIRE → Enoxaparin And Tnk-Tpa With Or Without Gp IIb/IIia Inhibitor As Reperfusion Strategy In St Elevation Mi (TIMI-23)
  26. ENT 38 → Phenothiazine
  27. ENaC → Epithelial sodium channel
  28. EOG → Electrooculography
  29. EP → Sudden cardiac death
  30. EPAMSA → Estudio Piloto Argentino De Muerte Subita Y Amioda Rone (Argentine Pilot Study Of Sudden Death And Amiodarone)
  31. EPAT → Estrogen In The Prevention Of Atherosclerosis Trial
  32. EPCR → Endothelial protein C receptor
  33. EPEC → Escherichia coli enteritis
  34. EPEC infection → Escherichia coli enteritis
  35. EPHESUS → Eplerenone Post-Ami Heart Failure Efficacy And Survival Study
  36. EPIC → Evaluation Of C7E3 For The Prevention Of Ischemic Complications
  37. EPILOG → Evaluation Of Ptca To Improve Long-Term Outcome By C7E3 Gp IIb/IIia Receptor (Abciximab) Blockade
  38. EPISTENT → Evaluation Of Platelet IIb/IIia Inhibitor For Stenting Trial
  39. EPIVIR → Lamivudine
  40. EPIVIR A/F → Lamivudine
  41. EPIVIR HBV → Lamivudine
  42. EPOCH-R regimen → DA-R-EPOCH regimen
  43. EPOCH Regimen → DA-EPOCH regimen
  44. EPOCH regimen → DA-EPOCH regimen
  45. EPOS → Elective Pci In Outpatient Study
  46. EPP (erythropoietic protoporphyria) → Porphyria
  47. EPS15 gene → EPS15
  48. EPSP → Excitatory postsynaptic potential
  49. EPTFE → Polytetrafluoroethylene
  50. EP Testing → Sudden cardiac death

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:ListRedirects"